Revenue

Inside the TIGER 21 summit where the world’s ultra-rich strategize on AI, global instability, and the $83 trillion wealth transfer.

A new model from an independent researcher proposes a 'pixel size' for spacetime and a mass limit where quantum reality ends, converging with a Nobel laureate.

An exclusive, invite-only conference in NYC highlights the explosive growth and strategic importance of GP stakes, gathering the industry's elite players.

With new CEO Dr. Hoshang Subawalla, AquaFortus pivots from R&D to global infrastructure, deploying its disruptive brine tech to rewrite water economics.

Arlington Dermatology Clinic joins a national network, highlighting a major trend in healthcare consolidation. What does this mean for DFW patients?

The nation's top IV therapy franchise reports record growth, but its expansion highlights a booming wellness industry navigating a complex regulatory landscape.

For the first time, NCH's heart institute earns national recognition, driven by AI-powered tech and a commitment to world-class care in Southwest Florida.

Ambience Healthcare appoints Mike Valli as CRO/CVO, signaling a bold new strategy to prove AI's ROI by tackling clinician burnout and revenue leakage.

The global investment bank's strategic move to join the 24X National Exchange signals a major validation for the extended-hours trading model.

A new pilot program uses AI to find hidden patterns in past cancer trial data, aiming to get the right drugs to the right patients, faster.

In a strategic move, American Beacon Partners names a new product head to navigate a complex market and deliver next-generation solutions for financial advisors.

Veteran ad expert Dave Saunders names the champions and flops of Super Bowl LX, revealing what works in an era of AI and celebrity-packed commercials.

For the second straight year, Vankyo is North America's top projector seller. We explore the strategy of innovation and retail power behind its rise.

With the hire of Kirk Sadler, Red Oak signals a major push to advance its AI-driven platform amid a heated RegTech market and rising regulatory pressure.

Top execs from finance and tech join Relay Resources' board, bringing corporate power to accelerate its disability inclusion and social enterprise goals.

With strong revenue, key AI upgrades, and a top Microsoft award, Blue Yonder is solidifying its market lead as global supply chain pressures intensify.

Waters finalized its $18.8B merger with BD's units, doubling its size. But investor concerns over near-term performance sent shares tumbling.

At Manifest 2026, Terminal Industries launched a new AI platform to automate yard operations, promising to fix a costly 'black hole' in the supply chain.

A new strategic alliance aims to bring complex peptide therapies to Europe and India, signaling a shift in global biopharma partnerships and patient access.

A new long-acting CBD injection shows major promise for arthritic dogs, and the company is now in talks with the FDA for human applications.